Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 August, 2018 12:38 IST
Aurobindo Pharma quarterly net declines 0.64%
Source: IRIS | 29 May, 2018, 12.02PM
Comments  |  Post Comment

N. Govindarajan, Managing Director of the company said, ''The company has reported a healthy growth in revenues and profitability in FY18, led by improvement in most of the markets. We continue to ramp up investment in differentiated and speciality product portfolio. Our execution strength and pipeline evolution will drive growth for the future.''



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Ion Exchange secures EPC contract worth Rs 4.38 bn - 17-Aug-2018 11:35
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
Ashok Leyland wins overseas order for 300 double decker buses - 17-Aug-2018 09:51
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
MCX inks MoU with Indian Bullion and Jewellers Association - 16-Aug-2018 15:31
Alfa Transformers bags order worth Rs 171.1 mn from Uttar Gujarat Vij Co - 16-Aug-2018 12:25
TVS Motor Co bets big on Philippines with new product launches - 16-Aug-2018 09:54
Sun Pharma gets USFDA approval for Cequa ophthalmic solution - 16-Aug-2018 09:33
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer